Trinity Biotech - 33 Year Stock Price History | TRIB
Historical daily share price chart and data for Trinity Biotech since 1992 adjusted for splits and dividends. The latest closing stock price for Trinity Biotech as of May 12, 2025 is 0.73.
- The all-time high Trinity Biotech stock closing price was 136.36 on January 16, 2014.
- The Trinity Biotech 52-week high stock price is 3.55, which is 386.3% above the current share price.
- The Trinity Biotech 52-week low stock price is 0.48, which is 34.2% below the current share price.
- The average Trinity Biotech stock price for the last 52 weeks is 1.45.
| Trinity Biotech Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 0.7444 | 0.9499 | 1.3600 | 0.5201 | 0.7301 | -17.05% |
| 2024 | 1.9634 | 2.1975 | 3.4600 | 0.7700 | 0.8802 | -58.97% |
| 2023 | 4.1112 | 5.3000 | 5.9000 | 1.8775 | 2.1450 | -56.67% |
| 2022 | 6.0935 | 7.1880 | 7.2000 | 4.6000 | 4.9500 | -30.77% |
| 2021 | 15.3580 | 18.0500 | 33.2000 | 7.1500 | 7.1500 | -62.47% |
| 2020 | 10.2946 | 5.3500 | 23.8500 | 3.1000 | 19.0500 | 268.69% |
| 2019 | 9.7142 | 11.5500 | 16.1000 | 3.4655 | 5.1670 | -54.87% |
| 2018 | 22.0923 | 25.9000 | 30.3000 | 10.7000 | 11.4500 | -55.10% |
| 2017 | 28.3044 | 34.8000 | 35.2000 | 22.5000 | 25.5000 | -26.30% |
| 2016 | 51.5808 | 58.4000 | 67.6500 | 31.5500 | 34.6000 | -41.16% |
| 2015 | 78.9764 | 89.6334 | 99.0165 | 54.1500 | 58.8000 | -32.00% |
| 2014 | 108.8977 | 121.8750 | 136.3570 | 79.2626 | 86.4728 | -29.70% |
| 2013 | 93.3023 | 70.9801 | 125.3980 | 70.4966 | 123.0000 | 76.41% |
| 2012 | 58.2187 | 48.1811 | 74.4614 | 46.9408 | 69.7230 | 43.57% |
| 2011 | 45.5158 | 39.2029 | 51.6634 | 38.0121 | 48.5627 | 20.36% |
| 2010 | 28.1498 | 18.2161 | 40.7600 | 17.5863 | 40.3478 | 118.07% |
| 2009 | 14.6881 | 7.5108 | 22.6699 | 4.8088 | 18.5023 | 152.50% |
| 2008 | 17.0043 | 30.1807 | 31.8294 | 5.7247 | 7.3276 | -76.51% |
| 2007 | 45.3212 | 40.2562 | 53.8124 | 26.1963 | 31.1887 | -20.54% |
| 2006 | 39.2482 | 37.6000 | 43.6911 | 32.4706 | 39.2487 | 5.02% |
| 2005 | 37.6072 | 53.6750 | 53.6750 | 28.7610 | 37.3710 | -31.08% |
| 2004 | 59.5896 | 97.2744 | 97.2744 | 46.3473 | 54.2245 | -46.95% |
| 2003 | 50.8460 | 26.5627 | 113.3770 | 22.8989 | 102.2210 | 313.33% |
| 2002 | 24.6597 | 27.4787 | 33.7072 | 17.0368 | 24.7308 | -11.18% |
| 2001 | 35.0465 | 41.2180 | 54.9573 | 20.8838 | 27.8450 | -32.44% |
| 2000 | 61.4169 | 32.0584 | 136.2480 | 32.0584 | 41.2180 | 33.33% |
| 1999 | 31.2940 | 26.9062 | 41.2180 | 21.1815 | 30.9135 | 28.57% |
| 1998 | 33.2693 | 37.7832 | 46.9427 | 17.1742 | 24.0438 | -33.33% |
| 1997 | 46.4506 | 42.3629 | 57.8197 | 29.7685 | 36.0657 | -16.00% |
| 1996 | 67.9619 | 66.4068 | 116.7840 | 41.2180 | 42.9354 | -39.52% |
| 1995 | 33.5123 | 35.4933 | 75.5663 | 17.1742 | 70.9865 | 87.88% |
| 1994 | 56.7340 | 70.9865 | 75.5663 | 33.2034 | 37.7832 | -45.00% |
| 1993 | 75.0983 | 75.5663 | 107.6250 | 50.3775 | 68.6966 | -11.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.014B | $0.057B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.526B | 27.00 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.916B | 30.93 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $109.157B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.583B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.109B | 26.80 |
| ResMed (RMD) | United States | $36.312B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.806B | 16.05 |
| Agilent Technologies (A) | United States | $32.907B | 21.74 |
| Terumo (TRUMY) | Japan | $27.953B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.765B | 16.36 |
| Insulet (PODD) | United States | $22.130B | 86.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.288B | 12.39 |
| Baxter (BAX) | United States | $15.985B | 11.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.381B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.091B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.462B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.298B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.605B | 9.14 |
| ICU Medical (ICUI) | United States | $3.534B | 26.06 |
| Haemonetics (HAE) | United States | $3.473B | 15.13 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| QuidelOrtho (QDEL) | United States | $2.401B | 16.52 |
| GN Store Nord (GNNDY) | Denmark | $2.164B | 17.92 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.06 |
| AtriCure (ATRC) | United States | $1.558B | 0.00 |
| Neogen (NEOG) | United States | $1.409B | 18.03 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.179B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.172B | 26.35 |
| BioLife Solutions (BLFS) | United States | $1.097B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 9.50 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.75 |
| Evolus (EOLS) | United States | $0.653B | 0.00 |
| CeriBell (CBLL) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.559B | 4.63 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.350B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.312B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.309B | 11.36 |
| Aurora Cannabis (ACB) | Canada | $0.290B | 51.60 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.97 |
| Canopy Growth (CGC) | Canada | $0.267B | 0.00 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Biote (BTMD) | United States | $0.214B | 6.02 |
| OraSure Technologies (OSUR) | United States | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Brainsway (BWAY) | Israel | $0.185B | 49.05 |
| Quanterix (QTRX) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.47 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.19 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Exagen (XGN) | United States | $0.120B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.101B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.077B | 10.71 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.020B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |